This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Feb;33(1):148.

doi: 10.1097/01.jcp.0000426192.98855.59.

Methylphenidate therapy, headaches and caffeine consumption

Boaz Musafia, Gilad Rosenberg

PMID: 23288246
DOI: 10.1097/01.jcp.0000426192.98855.59

Comment

Methylphenidate therapy, headaches and caffeine consumption

Boaz Musafia et al. J Clin Psychopharmacol. 2013 Feb.

. 2013 Feb;33(1):148.

doi: 10.1097/01.jcp.0000426192.98855.59.

Authors

Boaz Musafia, Gilad Rosenberg

PMID: 23288246
DOI: 10.1097/01.jcp.0000426192.98855.59

No abstract available

PubMed Disclaimer

Comment on

Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study.
Adler LA, Orman C, Starr HL, Silber S, Palumbo J, Cooper K, Berwaerts J, Harrison DD. Adler LA, et al. J Clin Psychopharmacol. 2011 Feb;31(1):108-14. doi: 10.1097/JCP.0b013e318203ea0a. J Clin Psychopharmacol. 2011. PMID: 21192153 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information